Dr. Aaron DiAntonio and Dr. Jeffrey Milbrandt, co-directors of the Needleman Center for Axonal Therapeutics and Neurometabolism, launched the new center with a symposium featuring Aaron’s PhD mentor, Dr. Thomas Schwarz. Dr. Schwarz, who is now a professor at Harvard, gave a talk titled “Moving and Removing Neuronal Mitochondria”. Other speakers included Dr. Ghazal Ashrafi, a new member of the Needleman Center, Dr. DiAntonio, and Dr. Rajesh Devraj, the Chief Scientific Officer of Disarm Therapeutics, the company scientifically co-founded by Aaron and Jeff to develop therapies targeting SARM1.